Binds D-Ala-D-Ala in peptidoglycan; long half-life allows weekly dosing
Interactions
No curated interaction pairs are recorded for Dalbavancin. This is not a statement that none exist — check a full interaction reference before combining.
Common adverse effects
Nausea
Headache
Diarrhea
Pharmacokinetics
Half-life
346 hours
Protein binding
93%
Pregnancy & lactation
Not recorded for Dalbavancin. Absence here means this database does not hold a category — not that the drug is safe in pregnancy or breastfeeding.
Sources
Assembled from: drug index, curated drug database.
